We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

301 hedge funds and large institutions have $5.84B invested in Ionis Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 103 increasing their positions, 89 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 35

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

16% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 89

3% more funds holding

Funds holding: 293 → 301 (+8)

2.47% more ownership

Funds ownership: 90.11% → 92.58% (+2.5%)

3% more capital invested

Capital invested by funds: $5.68B → $5.84B (+$155M)

17% less call options, than puts

Call options by funds: $71.6M | Put options by funds: $86.1M

Holders
301
Holders Change
+8
Holders Change %
+2.73%
% of All Funds
7.5%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
46
Increased
103
Reduced
89
Closed
35
Calls
$71.6M
Puts
$86.1M
Net Calls
-$14.5M
Net Calls Change
-$9.35M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$47.9M
2
Deutsche Bank
Deutsche Bank
Germany
+$45.2M
3
Bank of America
Bank of America
North Carolina
+$27.6M
4
BB
BB Biotech
Switzerland
+$26.6M
5
FCM
Farallon Capital Management
California
+$23.6M

Top Sellers

1
WRF
Waddell & Reed Financial
Kansas
-$31.3M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$25.2M
3
ClearBridge Investments
ClearBridge Investments
New York
-$20.3M
4
Invesco
Invesco
Georgia
-$10.2M
5
AG
Artal Group
Luxembourg
-$6.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$10.3M -$3.44M -65,669 -24%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$10.1M -$1.11M -21,195 -10%
Millennium Management
53
Millennium Management
New York
$9.79M +$5.05M +96,324 +100%
SGAM
54
Smith Group Asset Management
Texas
$9.29M -$2.13M -40,680 -18%
State Board of Administration of Florida Retirement System
55
State Board of Administration of Florida Retirement System
Florida
$8.68M +$14.1K +270 +0.2%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$8.68M -$255K -4,866 -3%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$7.81M -$209K -3,984 -3%
Group One Trading
58
Group One Trading
Illinois
$7.42M +$232K +4,438 +3%
SI
59
Scout Investments
Missouri
$7.29M +$277K +5,297 +4%
CS
60
Candriam SCA
Luxembourg
$7.25M +$1.73M +33,000 +30%
AC
61
Ascend Capital
California
$6.84M +$7.07M +134,994 New
Citigroup
62
Citigroup
New York
$6.79M +$27.3K +522 +0.4%
TA
63
Teachers Advisors
New York
$6.7M -$972K -18,562 -12%
Invesco
64
Invesco
Georgia
$6.66M -$10.2M -195,231 -60%
Natixis Advisors
65
Natixis Advisors
Massachusetts
$6.43M -$170K -3,241 -2%
UBS Group
66
UBS Group
Switzerland
$6.12M +$2.76M +52,681 +78%
Canada Pension Plan Investment Board
67
Canada Pension Plan Investment Board
Ontario, Canada
$6.02M -$1.53M -29,300 -20%
SIM
68
Sonora Investment Management
Arizona
$5.99M -$93.2K -1,779 -1%
TRSOTSOK
69
Teachers Retirement System of the State of Kentucky
Kentucky
$5.61M -$62.9K -1,200 -1%
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$5.57M +$5.47M +104,495 +1,930%
GC
71
Guggenheim Capital
Illinois
$5.21M +$226K +4,316 +4%
Axa
72
Axa
France
$5.2M +$5.37M +102,604 New
State of New Jersey Common Pension Fund D
73
State of New Jersey Common Pension Fund D
New Jersey
$5.07M – – –
PPA
74
Parametric Portfolio Associates
Washington
$4.68M -$348K -6,642 -7%
FCM
75
Frontier Capital Management
Massachusetts
$4.46M +$4.61M +87,944 New
1 2
3
4 5

IONS Hedge Fund Activity: Q3 2017 in Review

301 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q3 2017, worth a combined $5.84B — up 2.7% from $5.68B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IONS positions and 35 closed out — a net gain of 11 holders — while 103 added to existing stakes and 89 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $47.9M. The largest seller was Waddell & Reed Financial, cutting an estimated $31.3M.

  • 301 institutional investors held Ionis Pharmaceuticals (IONS) as of Q3 2017, up from 293 in Q2 2017.
  • Funds reported $5.84B of Ionis Pharmaceuticals stock for Q3 2017, up 2.7% quarter-over-quarter.
  • 46 funds opened new Ionis Pharmaceuticals positions in Q3 2017 and 35 closed out, a net change of +11 holders.
  • The largest Ionis Pharmaceuticals buyer in Q3 2017 was Wellington Management Group, an estimated $47.9M added.
  • The largest Ionis Pharmaceuticals seller in Q3 2017 was Waddell & Reed Financial, an estimated $31.3M sold.

Based on aggregated 13F filings for Q3 2017.